Beginner's Mind
Blueprints for Builders and Investors
Hosted by Christian Soschner
From pre-seed to post-IPO, every company—especially in deep tech, biotech, AI, and climate tech—lives or dies by the frameworks it follows.
On Beginner’s Mind, Christian Soschner uncovers the leadership principles behind the world’s most impactful companies—through deep-dive interviews, strategic book reviews, and patterns drawn from history’s greatest business, military, and political minds.
With over 200 interviews, panels, and livestreams, the show ranks in the Top 10% globally—and is recognized as the #1 deep tech podcast.
With 35+ years across M&A, company building, board roles, business schools, ultrarunning, and martial arts, Christian brings a rare lens:
What it really takes to turn breakthrough science into business—how to grow it, lead it, and shape the world around it.
🎙 Expect each episode to deliver:
- Founder & Investor Blueprints: How breakthrough technologies scale from lab to IPO
- Historical & Biographical Frameworks: Timeless playbooks from the world's great builders
- Leadership & Communication Mastery: Tools to inspire, persuade, and lead at scale
Whether you're building the next biotech success, investing in AI, or leading a climate tech company through hypergrowth—this podcast gives you the edge.
Listen in. Apply what matters. Build companies that last.
📬 Join the newsletter & community: https://lsg2g.substack.com/
Beginner's Mind
#104: Revolutionizing Respiratory Antivirals: The Science behind G.ST Antivirals
On this episode of "Year in Review Recording," we speak with Guido Gualdoni, Co-Founder, and CEO of G.ST Antivirals, a clinical-stage biotech company revolutionizing how we treat viral infections of the respiratory tract.
Guido shares the science behind G.ST Antivirals' innovative host cell-based strategy to develop broad-spectrum antivirals and how it completely eliminates viral reproduction without the risk of resistance development. He also delves into the public funding and startup ecosystem in Vienna, Austria, which has been instrumental in the company's success.
He also talks about the future plans for G.ST Antivirals and the deep scientific tech valley in Central Europe. This episode is a must-listen for anyone interested in the latest advancements in biotech and the companies leading the way in treating viral infections.
đź’ˇ LINKS TO MORE CONTENT.
If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
Podcast Episodes: https://pod.link/1493847125
Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2
Watch on Youtube
Guido Gualdoni
Christian Soschner
⏰ Timestamps:
(00:00) Welcome to the Episode: Exploring the Public Funding and Eco-System in Vienna, Austria
(02:35) Meet Guido Gualdoni, CEO of G.ST Antiviral
(04:00) Discovering the StartUp Labs, Vienna Business Agency, AWS, FFG, Austrian Business Agency, LISA Vienna and their role in supporting startups
(07:35) Exploring the Scientific Deep Tech Valley in Central Europe: Munich, Vienna, Zurich, Prague
(10:15) G.ST Antiviral's 2022 Outlook
(11:22) Uncovering the Innovative Technology Behind G.ST Antiviral
(14:30) Guido's Biggest Takeaways from 2022
(16:15) Why Optimism Bias Can be a Challenge for Entrepreneurs
(18:15) Comparing the Scientific and Entrepreneurial Mindsets
(24:00) The Surprising Companies that Succeeded During Economic Downturns
(25:00) Examining the Latest Trends in Antiinfectious Diseases
(27:45) Charting the Growth of G.ST Antiviral in 2023
Join the Podcast Newsletter: Link
